Skip to Content

M 274 (Tamoxifen 20 mg)

This pill with imprint "M 274" is White, Round and has been identified as Tamoxifen citrate 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer, male; breast cancer, prevention; breast cancer (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tamoxifen citrate 20 mg M 274
Tamoxifen citrate 20 mg M 274 Front
Tamoxifen citrate 20 mg M 274 Back
Tamoxifen citrate 20 mg M 274

Tamoxifen citrate

Imprint:
M 274
Strength:
20 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide